Drugs / FIT-(BCMA+CD19)-CAR-T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07604792 | Sep → Nov 2025 | autoimmune disease | Beijing Boren Hospital | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FIT-(BCMA+CD19)-CAR-T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07604792 ↗ |
| Modality | Cell therapy | “CAR-T cell therapy” NCT07604792 ↗ |